Search

everythinglearnresearchcommunity

for

Search:↓

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Certain gene variations may increase the risk and severity of alopecia areata.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

Alopecia areata patients have a higher risk of other immune-related diseases.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Plucked hair can help diagnose pemphigus vulgaris early.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Skin tumors and normal skin structures have different lectin-binding patterns.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

miR-155-5p can help diagnose and track alopecia areata severity.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Many children with alopecia areata also have other autoimmune diseases.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Alopecia areata patients often have autoimmune disorders, especially thyroid issues.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.